Prem Watsa (Trades, Portfolio), through his hedge fund Fairfax Financial Holdings, manages a portfolio composed of 49 stocks with a value of $1,364 million.
With help from the All-In-One Screener, the following are the stocks in his portfolio with the highest return since the beginning of the year.
He holds 22,100 shares of Geeknet Inc. (GKNT) that has returned 141.30% year-to-date. The stake represents 0.33% of outstanding shares of the company and 0.03% of his total assets.
Geeknet is the parent company of ThinkGeek Inc. an online premier retailer for the global geek community, comprised of technology enthusiasts and general consumers of geek-themed, technology-oriented and popular culture goods.
During the last quarter, total revenue decreased by 16% from the first quarter of a year before, which reflects their strategy to reduce site-wide promotions and low productivity SKUs.
The stock is trading with a forward P/E ratio of 105.26; in the last 12 months the price has risen by 118%.
Geeknet has a profitability and growth rating of 4 out of 10 with negative returns (ROE -15.77%, ROA –12.90%) that are underperforming 92% of the companies in the Global Specialty Retail industry. Financial strength has a rating of 4 out of 10.
Paul Tudor Jones (Trades, Portfolio) is the main guru shareholder with 3.92% of outstanding shares, followed by Jim Simons (Trades, Portfolio) with 1.92%.
Watsa holds 75,000 shares of Lumenis Ltd. (LMNS) that has returned 46.80% year-to-date. The stake represents 0.21% of outstanding shares of the company and 0.08% of his total assets.
The company is a provider of energy-based, minimally invasive clinical solutions for both medically necessary and elective procedures, for the aging population.
Lumenis reported a 9.3% increase in revenue and 31.1% increase for adjusted EBITDA year over year. Driven by the combination of successful sales execution and the early adoption of newly launched products, the company will continue to report solid revenue growth year-over-year.
The stock is trading with a P/E ratio of 28.06; in the last 12 months the price has risen by 52%, and is now 1.79% below its 52-week high and 62.37% above its 52-week low. It looks overpriced at the current price of $13.72. The DCF calculator gives a fair value of $7.23, estimating the stock is overvalued by 90%. The Peter Lynch earnings line gives a lower fair value of $6.20.
GuruFocus gives Lumenis a profitability and growth rating of 5 out of 10 with good returns (ROE 18.77%, ROA 6.32%) that are outperforming 73% of the companies in the Global Medical Devices industry. Financial strength has a rating of 8 out of 10, with a cash to debt of 2.05 that is slightly below the industry median of 2.24.
Paul Tudor Jones (Trades, Portfolio) is the main guru shareholder of the company with 2.78% of outstanding shares, followed by Jim Simons (Trades, Portfolio) with 0.51%.
Watsa holds 11,200 shares of Advent Software Inc. (ADVS), which has returned 44.4% year-to-date. The stake represents 0.02% of outstanding shares of the company and 0.04% of his total assets.
The company offers software and services that automate work flows and data across investment management organizations, as well as the information flows between an investment management organization and external parties. Its products are intended to increase operational efficiency, improve the accuracy of client information and enable better decision-making.
Advent's business achieved record quarterly revenue in the first quarter. Quarterly revenues was up by 7% from the same quarter of a year before. Operating income was 9.9% of revenue, compared to 20.0% of revenue for the first quarter of 2014.
The stock is trading with a P/E ratio of 53.70; in the last 12 months the price has risen by 41%. It looks overpriced at the current price of $44.24. The DCF calculator gives a fair value of $12.1, estimating the stock is overvalued by 266%. The Peter Lynch earnings line gives a fair value of $13.1.
GuruFocus gives Advent a profitability and growth rating of 8 out of 10 with good returns (ROC 257.57%, ROA 10.10%) that are outperforming 80% of the other companies in the Global Software - Application industry. Financial strength has a rating of 8 out of 10, with a cash to debt of 0.14 that is far below the industry median of 18.85.
Jim Simons (Trades, Portfolio) is the main guru shareholder of the company with 3.76% of outstanding shares, followed by Mario Gabelli (Trades, Portfolio) with 0.88% and Ron Baron (Trades, Portfolio) with 0.52%.
Watsas also holds 20,000 shares of Hologic Inc. (HOLX) that has returned 40.10% year-to-date. The stake represents 0.01% of outstanding shares of the company.
The company is a developer, manufacturer and supplier of medical imaging systems and diagnostic and surgical products focused on the healthcare needs of women. Its core business segments are focused on breast health, diagnostics, GYN surgical and skeletal health.
Hologic posted strong organic revenue growth across the board for the second quarter. It reported revenue with a growth of 4.9% year over year.
The stock is trading with a P/E ratio of 79.68; in the last 12 months the price has risen by 55%, and is now 13.49% below its 52-week high and 63.88% above its 52-week low. It looks overpriced at the current price of $37.2. The DCF calculator gives a fair value of $6.93, estimating the stock is overvalued by 437%. The Peter Lynch earnings line gives a fair value of $6.6.
GuruFocus gives Hologic a profitability and growth rating of 5 out of 10 with positive returns such as ROE 18.77%, ROA 6.32%, that are outperforming 73% of the companies in the Global Medical Devices industry. Financial strength has a rating of 8 out of 10, with a cash to debt of 2.05 that is below the industry median of 2.24.
Carl Icahn (Trades, Portfolio) is the main guru shareholder of the company with a stake of 12.12% of outstanding shares, followed by Vanguard Health Care Fund (Trades, Portfolio) with 2.62% and Kahn Brothers (Trades, Portfolio) with 0.48%.
Watsa holds 35,000 shares of Nam Tai Property Inc. (NTP) that has returned 35.0% year-to-date. The stake represents 0.08% of outstanding shares of the company and 0.01% of his total assets.
The company, along with its subsidiaries, is an electronics manufacturing and design services provider to OEMs of telecommunications and consumer electronic products. It manufactures electronic components and subassemblies, including FPC board, FPC board subassemblies, thin film transistor display modules, image sensors modules and printed circuit board assemblies.
The stock is trading with a P/E ratio of 252.40; in the last 12 months the price has risen by 16%, and is now 4.25% below its 52-week high and 79.77% above its 52-week low. It looks overpriced at the current price of $6.31. The Peter Lynch earnings line gives a fair value of $1.1.
Nam Tai has a profitability and growth rating of 5 out of 10 with weak returns (ROE 0.42%, ROA 0.36%) that are underperforming 70% of other companies in the Global Electronic Components industry. Financial strength has a rating of 7 out of 10, with a cash to debt of 5.43 that is above the industry median of 1.36.
Kahn Brothers (Trades, Portfolio) is the main guru shareholder of the company with 6.84% of outstanding shares, followed by Prem Watsa (Trades, Portfolio) with 0.08%. Jim Simons (Trades, Portfolio) sold out his stake during the last quarter.
Watsa also holds 34,000 shares of Polypore International Inc. (PPO) that has returned 28.50% year-to-date. The stake represents 0.08% of outstanding shares of the company and 0.15% of his total assets.
It is a high technology filtration company that develops, manufactures and markets specialized microporous membranes used in separation and filtration processes.
The stock is trading with a P/E ratio of 54.40; in the last 12 months the price has risen by 65%. It looks overpriced at the current price of $60.48. The DCF calculator gives a fair value of $16.52, estimating the stock is overvalued by 266%. The Peter Lynch earnings line gives a fair value of $15.2.
GuruFocus gives Polypore a profitability and growth rating of 7 out of 10 with weak returns (ROE 8.23%, ROA 3.55%). Financial strength has a rating of 7 out of 10, with a cash to debt of 0.10 that is below the industry median of 0.99.
PRIMECAP Management (Trades, Portfolio) is the main guru shareholder of the company with 11.35% of outstanding shares, followed by Jim Simons (Trades, Portfolio) with 1.41% and Mario Gabelli (Trades, Portfolio) with 0.56%.
The list is completed with the following stocks:
New York Community Bancorp Inc. (NYCB) with a year-to-date return of 19.80%, K12 Inc. (LRN) with a return of 13.60%, Old Republic International Corporation (ORI) +12,30%, Pfizer Inc. (PFE) +8%, OmniVision Technologies Inc. (OVTI) +7.50%, New Oriental Education & Technology Group Inc. (EDU) +7%, Sterling Bancorp (STL) +5.30%, Dresser-Rand Group Inc. (DRC) +4.10%, General Dynamics Corp (GD) +3.70%, Patterson-UTI Energy Inc. (PTEN) +2.40%
